Herpetic Eye Disease Following the SARS-CoV-2 Vaccinations

References

• WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int/. Accessed December 15, 2021.
   Google Scholar
• Rawat K, Kumari P, Saha L. COVID-19 vaccine: a recent update in pipeline vaccines, their design and development strategies. Eur J Pharmacol. 2021 Feb 5;892:173751. doi:10.1016/j.ejphar.2020.173751.
   PubMed Web of Science ®Google Scholar
• Coronavirus disease (COVID-19): vaccines. https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-vaccines. Accessed December 15, 2021.
   Google Scholar
• COVID-19 vaccines. https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/covid-19-vaccines. Accessed January 08, 2022.
   Google Scholar
• Bar-On YM, Goldberg Y, Mandel M, et al. Protection of BNT162b2 vaccine booster against Covid-19 in Israel. N Engl J Med. 2021;385(15):1393–1400. doi:10.1056/NEJMoa2114255.
   PubMed Web of Science ®Google Scholar
• COVID-19 virus in Israel: general situation report. https://datadashboard.health.gov.il/COVID-19/general. Accessed December 18, 2021.
   Google Scholar
• Dagan N, Barda N, Kepten E, et al. BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting. N Engl J Med. 2021 Apr 15;384(15):1412–1423. doi:10.1056/NEJMoa2101765.
   PubMed Web of Science ®Google Scholar
• Haas EJ, Angulo FJ, McLaughlin JM, et al. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. Lancet. 2021 May 15;397(10287):1819–1829. doi:10.1016/s0140-6736(21)00947-8.
   PubMed Web of Science ®Google Scholar
• Spitzer A, Angel Y, Marudi O, et al. Association of a third dose of BNT162b2 vaccine with incidence of SARS-CoV-2 infection among health care workers in Israel. Jama. 2022 Jan 10. doi:10.1001/jama.2021.23641.
   PubMed Web of Science ®Google Scholar
• Mofaz M, Yechezkel M, Guan G, et al. Self-reported and physiological reactions to the third BNT162b2 mRNA COVID-19 (booster) vaccine dose. medRxiv. 2021 Sep 15:21263633. doi:10.1101/2021.09.15.21263633.
   Google Scholar
• Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020 Dec 31;383(27):2603–2615. doi:10.1056/NEJMoa2034577.
   PubMed Web of Science ®Google Scholar
• Thomas SJ, Moreira ED, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months. N Engl J Med. 2021;385(19):1761–1773. doi:10.1056/NEJMoa2110345.
   PubMed Web of Science ®Google Scholar
• Li J, Hui A, Zhang X, et al. Safety and immunogenicity of the SARS-CoV-2 BNT162b1 mRNA vaccine in younger and older Chinese adults: a randomized, placebo-controlled, double-blind phase 1 study. Nat Med. 2021 Jun;27(6):1062–1070. doi:10.1038/s41591-021-01330-9.
   PubMed Web of Science ®Google Scholar
• Furer V, Zisman D, Kibari A, Rimar D, Paran Y, Elkayam O. Herpes zoster following BNT162b2 mRNA COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: a case series. Rheumatology (Oxford). 2021 Oct 9;60(Si):Si90–si95. doi:10.1093/rheumatology/keab345.
   PubMedGoogle Scholar
• Alpalhão M, Filipe P. Herpes Zoster following SARS-CoV-2 vaccination - a series of four cases. J Eur Acad Dermatol Venereol. 2021 Nov;35(11):e750–e752. doi:10.1111/jdv.17555.
   PubMed Web of Science ®Google Scholar
• Català A, Muñoz-Santos C, Galván-Casas C, et al. Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases. Br J Dermatol. 2021 Jul 13;186(1):142–152. doi:10.1111/bjd.20639.
   PubMed Web of Science ®Google Scholar
• Chiu HH, Wei KC, Chen A, Wang WH. Herpes zoster following COVID-19 vaccine: a report of three cases. Qjm. 2021 Nov 5;114(7):531–532. doi:10.1093/qjmed/hcab208.
   PubMed Web of Science ®Google Scholar
• Lee C, Cotter D, Basa J, Greenberg HL. 20 Post-COVID-19 vaccine-related shingles cases seen at the Las Vegas Dermatology clinic and sent to us via social media. J Cosmet Dermatol. 2021 Jul;20(7):1960–1964. doi:10.1111/jocd.14210.
   PubMed Web of Science ®Google Scholar
• Psichogiou M, Samarkos M, Mikos N, Hatzakis A. Reactivation of varicella zoster virus after vaccination for SARS-CoV-2. Vaccines (Basel). 2021 1 Jun;9(6). doi:10.3390/vaccines9060572.
   Web of Science ®Google Scholar
• Rodríguez-Jiménez P, Chicharro P, Cabrera L-M. et al. Varicella-zoster virus reactivation after SARS-CoV-2 BNT162b2 mRNA vaccination: report of 5 cases. JAAD Case Rep. 2021;12:58–59. doi:10.1016/j.jdcr.2021.04.014.
   PubMedGoogle Scholar
• Tessas I, Kluger N. Ipsilateral herpes zoster after the first dose of BNT162b2 mRNA COVID-19 vaccine. J Eur Acad Dermatol Venereol. 2021 Oct;35(10):e620–e622. doi:10.1111/jdv.17422.
   PubMed Web of Science ®Google Scholar
• Barda N, Dagan N, Ben-Shlomo Y, et al. Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting. N Engl J Med. 2021 Sep 16;385(12):1078–1090. doi:10.1056/NEJMoa2110475.
   PubMed Web of Science ®Google Scholar
• van Dam CS, Lede I, Schaar J, Al-Dulaimy M, Rösken R, Smits M. Herpes zoster after COVID vaccination. Int J Infect Dis. 2021 Oct;111:169–171. doi:10.1016/j.ijid.2021.08.048.
   PubMed Web of Science ®Google Scholar
• Fathy RA, McMahon DE, Lee C, et al. Varicella-zoster and herpes simplex virus reactivation post-COVID-19 vaccination: a review of 40 cases in an International Dermatology Registry. J Eur Acad Dermatol Venereol. 2022 Jan;36(1):e6–e9. doi:10.1111/jdv.17646.
   PubMed Web of Science ®Google Scholar
• Koumaki D, Krueger-Krasagakis SE, Papadakis M, et al. Herpes zoster viral infection after AZD1222 and BNT162b2 coronavirus disease 2019 mRNA vaccines: a case series. J Eur Acad Dermatol Venereol. 2021 Oct 4;36(2):e85–e86. doi:10.1111/jdv.17720.
   PubMed Web of Science ®Google Scholar
• Santovito LS, Pinna G. A case of reactivation of varicella-zoster virus after BNT162b2 vaccine second dose? Inflamm Res. 2021 Sep;70(9):935–937. doi:10.1007/s00011-021-01491-w.
   PubMed Web of Science ®Google Scholar
• Rabinovitch T, Ben-Arie-Weintrob Y, Hareuveni-Blum T, et al. Uveitis after the BNT162b2 mRNA vaccination against SARS-CoV-2 infection: a possible association. Retina. 2021 Dec 1;41(12):2462–2471. doi:10.1097/iae.0000000000003277.
   PubMed Web of Science ®Google Scholar
• Renisi G, Lombardi A, Stanzione M, Invernizzi A, Bandera A, Gori A. Anterior uveitis onset after bnt162b2 vaccination: is this just a coincidence? Int J Infect Dis. 2021 Sep;110:95–97. doi:10.1016/j.ijid.2021.07.035.
   PubMed Web of Science ®Google Scholar
• Fowler N, Mendez Martinez NR, Pallares BV, Maldonado RS. Acute-onset central serous retinopathy after immunization with COVID-19 mRNA vaccine. Am J Ophthalmol Case Rep. 2021 Sep;23:101136. doi:10.1016/j.ajoc.2021.101136.
   PubMedGoogle Scholar
• Wasser LM, Roditi E, Zadok D, Berkowitz L, Weill Y. Keratoplasty rejection after the BNT162b2 messenger RNA vaccine. Cornea. 2021 Aug 1;40(8):1070–1072. doi:10.1097/ico.0000000000002761.
   PubMed Web of Science ®Google Scholar
• Phylactou M, Li JO, Larkin DFP. Characteristics of endothelial corneal transplant rejection following immunisation with SARS-CoV-2 messenger RNA vaccine. Br J Ophthalmol. 2021 Jul;105(7):893–896. doi:10.1136/bjophthalmol-2021-319338.
   PubMed Web of Science ®Google Scholar
• Crnej A, Khoueir Z, Cherfan G, Saad A. Acute corneal endothelial graft rejection following COVID-19 vaccination. J Fr Ophtalmol. 2021 Oct;44(8):e445–e447. doi:10.1016/j.jfo.2021.06.001.
   PubMed Web of Science ®Google Scholar
• Mudie LI, Zick JD, Dacey MS, Palestine AG. Panuveitis following vaccination for COVID-19. Ocul Immunol Inflamm. 2021 May 19;29(4):741–742. doi:10.1080/09273948.2021.1949478.
   PubMed Web of Science ®Google Scholar
• Koong LR, Chee WK, Toh ZH, Ng XL, Agrawal R, Ho SL. Vogt-Koyanagi-Harada disease associated with COVID-19 mRNA vaccine. Ocul Immunol Inflamm. 2021 Sep 10:1–4. doi:10.1080/09273948.2021.1974492.
   Google Scholar
• Papasavvas I, Herbort CP Jr. Reactivation of Vogt-Koyanagi-Harada disease under control for more than 6 years, following anti-SARS-CoV-2 vaccination. J Ophthalmic Inflamm Infect. 2021 Jul 5;11(1):21. doi:10.1186/s12348-021-00251-5.
   PubMed Web of Science ®Google Scholar
• Valenzuela DA, Groth S, Taubenslag KJ, Gangaputra S. Acute macular neuroretinopathy following Pfizer-BioNTech COVID-19 vaccination. Am J Ophthalmol Case Rep. 2021 Dec;24:101200. doi:10.1016/j.ajoc.2021.101200.
   PubMedGoogle Scholar
• Koh JS, Hoe RHM, Yong MH, et al. Hospital-based observational study of neurological disorders in patients recently vaccinated with COVID-19 mRNA vaccines. J Neurol Sci. 2021 Nov 15;430:120030. doi:10.1016/j.jns.2021.120030.
   PubMed Web of Science ®Google Scholar
• Papasavvas I, de Courten C, Herbort CP Jr. Varicella-zoster virus reactivation causing herpes zoster ophthalmicus (HZO) after SARS-CoV-2 vaccination - report of three cases. J Ophthalmic Inflamm Infect. 2021 Sep 16;11(1):28. doi:10.1186/s12348-021-00260-4.
   PubMed Web of Science ®Google Scholar
• Iwai S, Takayama K, Sora D, Takeuchi M. A case of acute retinal necrosis associated with reactivation of varicella zoster virus after COVID-19 vaccination. Ocul Immunol Inflamm. 2021 Nov 22:1–3. doi:10.1080/09273948.2021.2001541.
   PubMed Web of Science ®Google Scholar
• Alkhalifah MI, Alsobki HE, Alwael HM, Al Fawaz AM, Al-Mezaine HS. Herpes simplex virus keratitis reactivation after SARS-CoV-2 BNT162b2 mRNA vaccination: a report of two cases. Ocul Immunol Inflamm. 2021 Oct 12:1–3. doi:10.1080/09273948.2021.1986548.
   Web of Science ®Google Scholar
• Song MY, Koh KM, Hwang KY, Kwon YA, Kim KY. Relapsed disciform stromal herpetic keratitis following mRNA COVID-19 vaccination. Korean J Ophthalmol. 2021 Nov 26. doi:10.3341/kjo.2021.0150.
   Google Scholar
• Bolletta E, Iannetta D, Mastrofilippo V, et al. Uveitis and other ocular complications following COVID-19 vaccination. J Clin Med. 2021 Dec 19;10(24):5960. doi:10.3390/jcm10245960.
   PubMed Web of Science ®Google Scholar
• Holloway K, Green T Drug and therapeutics committees: a practical guide. World Health Organization; 2003. https://apps.who.int/iris/handle/10665/68553
   Google Scholar
• Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981 Aug;30(2):239–245. doi:10.1038/clpt.1981.154.
   PubMed Web of Science ®Google Scholar
• Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of Uveitis Nomenclature Working G. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005 Sep;140(3):509–516. doi:10.1016/j.ajo.2005.03.057.
   PubMed Web of Science ®Google Scholar
• Standardization of Uveitis Nomenclature Working G. Classification criteria for varicella zoster virus anterior uveitis. Am J Ophthalmol. 2021 Aug;228:165–173. doi:10.1016/j.ajo.2021.03.037.
   PubMed Web of Science ®Google Scholar
• Standardization of Uveitis Nomenclature Working G. Classification criteria for herpes simplex virus anterior uveitis. Am J Ophthalmol. 2021 Aug;228:231–236. doi:10.1016/j.ajo.2021.03.053.
   PubMed Web of Science ®Google Scholar
• Rehman O, Arya SK, Jha UP, Nayyar S, Goel I. Herpes zoster ophthalmicus after COVID-19 vaccination: chance occurrence or more than that? Cornea. 2021 Oct 23. doi:10.1097/ico.0000000000002881.
   Web of Science ®Google Scholar
• Mishra SB, Mahendradas P, Kawali A, Sanjay S, Shetty R. Reactivation of varicella zoster infection presenting as acute retinal necrosis post COVID 19 vaccination in an Asian Indian male. Eur J Ophthalmol. 2021 Sep 18. doi:10.1177/11206721211046485.
   Web of Science ®Google Scholar
• Sanjay SPD, Kumar S, Rao VK R, Kawali A, Mahendradas P. Herpes zoster reactivation after COVID-19 vaccination in patients with autoimmune diseases. Indian J Rheumato. 2021 Dec 27. Epub ahead of print.
   PubMed Web of Science ®Google Scholar
• Ardalan M, Moslemi H, Shafiei S, Tabrizi R, Moselmi M. Herpes-like skin lesion after AstraZeneca vaccination for COVID-19: a case report. Clin Case Rep. 2021;9(10):e04883–e04883. doi:10.1002/ccr3.4883.
   PubMed Web of Science ®Google Scholar
• Richardson-May J, Rothwell A, Rashid M. Reactivation of herpes simplex keratitis following vaccination for COVID-19. BMJ Case Rep. 2021;14(9):e245792. doi:10.1136/bcr-2021-245792.
   PubMedGoogle Scholar
• Herbort CP Jr., Papasavvas I. Effect of SARS-CoV-2 mRNA vaccination on ocular herpes simplex and varicella-zoster virus reactivation: should preventive antiviral treatment be given in known herpes patients. J Ophthalmic Inflamm Infect. 2021 Sep 17;11(1):33. doi:10.1186/s12348-021-00262-2.
   PubMed Web of Science ®Google Scholar
• Li S, Jia X, Yu F, Wang Q, Zhang T, Yuan J. Herpetic keratitis preceded by COVID-19 vaccination. Vaccines (Basel). 2021;9(12):1394. doi:10.3390/vaccines9121394.
   PubMed Web of Science ®Google Scholar
• Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965 May;58(5):295–300.
   PubMedGoogle Scholar
• Hwang CW Jr., Steigleman WA, Saucedo-Sanchez E, Tuli SS. Reactivation of herpes zoster keratitis in an adult after varicella zoster vaccination. Cornea. 2013 Apr;32(4):508–509. doi:10.1097/ICO.0b013e318277acae.
   PubMed Web of Science ®Google Scholar
• Khalifa YM, Jacoby RM, Margolis TP. Exacerbation of zoster interstitial keratitis after zoster vaccination in an adult. Arch Ophthalmol. 2010;128(8):1079–1080. doi:10.1001/archophthalmol.2010.142.
   PubMed Web of Science ®Google Scholar
• Jastrzebski A, Brownstein S, Ziai S, Saleh S, Lam K, Jackson WB. Reactivation of herpes zoster keratitis with corneal perforation after zoster vaccination. Cornea. 2017 Jun;36(6):740–742. doi:10.1097/ico.0000000000001203.
   PubMed Web of Science ®Google Scholar
• Sham CW, Levinson RD. Uveitis exacerbation after varicella-zoster vaccination in an adult. Arch Ophthalmol. 2012 Jun;130(6):793–794. doi:10.1001/archophthalmol.2011.1881.
   PubMed Web of Science ®Google Scholar
• Charkoudian LD, Kaiser GM, Steinmetz RL, Srivastava SK. Acute retinal necrosis after herpes zoster vaccination. Arch Ophthalmol. 2011 Nov;129(11):1495–1497. doi:10.1001/archophthalmol.2011.320.
   PubMed Web of Science ®Google Scholar
• Nagpal A, Vora R, Margolis TP, Acharya NR. Interstitial keratitis following varicella vaccination. Arch Ophthalmol. 2009 Feb;127(2):222–223. doi:10.1001/archophthalmol.2008.569.
   PubMedGoogle Scholar
• Menghini M, Raja V, Raiter J, Balaratnasingam C, Constable IJ. acute retinal necrosis associated with herpes zoster vaccination. Retin Cases Brief Rep. 2021 Mar 1;15(2):166–168. doi:10.1097/icb.0000000000000761.
   PubMedGoogle Scholar
• Gonzales JA, Levison AL, Stewart JM, Acharya NR, Margolis TP. Retinal necrosis following varicella-zoster vaccination. Arch Ophthalmol. 2012 Oct;130(10):1355–1356. doi:10.1001/archophthalmol.2012.2255.
   PubMedGoogle Scholar
• Ali A, Kirschenbaum MD, Sharma S, Wandel TL. acute retinal necrosis and contralateral cutaneous eruption after the shingles vaccine. Retin Cases Brief Rep. 2021 Jan 1;15(1):43–44. doi:10.1097/icb.0000000000000729.
   PubMedGoogle Scholar
• Heath G, Depledge DP, Brown JR, et al. Acute retinal necrosis caused by the zoster vaccine virus. Clin Infect Dis. 2017 Nov 29;65(12):2122–2125. doi:10.1093/cid/cix683.
   PubMed Web of Science ®Google Scholar
• Esmaeli-Gutstein B, Winkelman JZ. Uveitis associated with varicella virus vaccine. Am J Ophthalmol. 1999 Jun;127(6):733–734. doi:10.1016/s0002-9394(99)00059-8.
   PubMed Web of Science ®Google Scholar
• Naseri A, Good WV, Cunningham ET Jr. Herpes zoster virus sclerokeratitis and anterior uveitis in a child following varicella vaccination. Am J Ophthalmol. 2003 Mar;135(3):415–417. doi:10.1016/s0002-9394(02)01957-8.
   PubMed Web of Science ®Google Scholar
• Chen RI, Deaner JD, Srivastava SK, Lowder CY. Acute retinal necrosis following recombinant subunit varicella-zoster virus vaccine. Am J Ophthalmol Case Rep. 2020 Dec;20:100962. doi:10.1016/j.ajoc.2020.100962.
   PubMedGoogle Scholar
• Jabbour S, Shekhawat NS, Chen A, Woreta FA. Presumed herpes zoster ophthalmicus reactivation following recombinant zoster vaccination. Cornea. 2021 Feb 1;40(2):248–250. doi:10.1097/ico.0000000000002537.
   PubMed Web of Science ®Google Scholar
• DiNardo AR, Netea MG, Musher DM, Longo DL. Postinfectious epigenetic immune modifications - a double-edged sword. N Engl J Med. 2021 Jan 21;384(3):261–270. doi:10.1056/NEJMra2028358.
   PubMed Web of Science ®Google Scholar
• Benn CS, Fisker AB, Rieckmann A, Sørup S, Aaby P. Vaccinology: time to change the paradigm? Lancet Infect Dis. 2020 Oct;20(10):e274–e283. doi:10.1016/s1473-3099(19)30742-x.
   PubMed Web of Science ®Google Scholar